Pain
📧 Sign up to get email alerts when something new happens for Pain.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2023-09-29FDA Approved: OXYCODONE AND ACETAMINOPHEN — Supplemental Application (Granules Pharmaceuticals Inc.)
FDA approved a supplemental application for Granules Pharmaceuticals Inc.'s generic oxycodone/acetaminophen product.
-
FDA approval · 2023-09-27FDA Approved: METHADONE HYDROCHLORIDE — Supplemental Application (VistaPharm, LLC)
FDA approved a supplemental application for methadone hydrochloride from VistaPharm, LLC, indicating approval of a supplemental submission f…
-
FDA approval · 2023-08-10FDA Approved: KETOROLAC TROMETHAMINE — Supplemental Application (Nephron Pharmaceuticals Corporation)
FDA approved a supplemental application for Ketorolac Tromethamine from Nephron Pharmaceuticals Corporation, indicating approval of an updat…
-
FDA approval · 2023-08-08FDA Approved: KETOROLAC TROMETHAMINE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for Ketorolac Tromethamine from Sun Pharmaceutical Industries, confirming continued marketing of the…
-
FDA approval · 2023-08-08FDA Approved: IBUPROFEN INFANTS — Original Application (Sun Pharmaceutical Industries, Inc.)
FDA approved Sun Pharmaceutical's Ibuprofen Infants as an original application generic ibuprofen product intended for infants.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2023-07-10FDA Approved: KETOROLAC TROMETHAMINE — Supplemental Application (Onesource Specialty Pharma Limited)
FDA approved a supplemental application for Ketorolac tromethamine (generic) submitted by Onesource Specialty Pharma Limited under an ANDA (…
-
FDA approval · 2023-06-26FDA Approved: BUPRENORPHINE HYDROCHLORIDE — Supplemental Application (PAI Holdings, LLC dba Pharmaceutical Associates, Inc. and dba PAI Pharma)
The FDA approved a supplemental application for buprenorphine hydrochloride (generic buprenorphine HCl) submitted by PAI Holdings/PAI Pharma…
-
FDA approval · 2023-06-20FDA Approved: KETOROLAC TROMETHAMINE — Original Application (Camber Pharmaceuticals, Inc.)
FDA approved Ketorolac tromethamine as an Original Application generic for Camber Pharmaceuticals, Inc., adding a new generic entry to the m…
-
FDA approval · 2023-06-14FDA Approved: BUPRENORPHINE — Supplemental Application (Actavis Pharma, Inc.)
FDA approved a supplemental application for buprenorphine from Actavis Pharma, Inc., indicating regulatory approval related to this generic …
-
FDA approval · 2023-06-05FDA Approved: BUPRENORPHINE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved Sun Pharmaceutical Industries' supplemental application for buprenorphine.
-
FDA approval · 2023-05-10FDA Approved: KETOROLAC TROMETHAMINE — Original Application (Caplin Steriles Limited)
The FDA approved the original application for a generic ketorolac tromethamine product from Caplin Steriles Limited.
-
FDA approval · 2023-03-16FDA Approved: PRIALT — Supplemental Application (TerSera Therapeutics LLC)
The FDA approved TerSera Therapeutics LLC's supplemental application for PRIALT (ziconotide acetate).
-
FDA approval · 2023-02-23FDA Approved: KETOROLAC TROMETHAMINE — Original Application (Bionpharma Inc.)
FDA approved a generic ketorolac tromethamine product from Bionpharma Inc. (ANDA 216759) for short-term management of moderate to severe pai…
-
FDA approval · 2023-02-23FDA Approved: KETOROLAC TROMETHAMINE — Original Application (Leading Pharma, LLC)
FDA approves Ketorolac tromethamine from Leading Pharma, LLC under an Original Application for a generic formulation.
-
FDA approval · 2022-12-16FDA Approved: BUPRENORPHINE HYDROCHLORIDE — Supplemental Application (PAI Holdings, LLC dba Pharmaceutical Associates, Inc. and dba PAI Pharma)
The FDA approved a supplemental application for buprenorphine hydrochloride under an Abbreviated New Drug Application from PAI Holdings, LLC…
-
FDA approval · 2022-12-16FDA Approved: BUPRENORPHINE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for Hikma Pharmaceuticals USA Inc. to market a buprenorphine generic product under ANDA 078633.
-
FDA approval · 2022-12-14FDA Approved: METHADONE HYDROCHLORIDE — Supplemental Application (VistaPharm, LLC)
FDA approved a supplemental application for methadone hydrochloride submitted by VistaPharm, LLC.
-
FDA approval · 2022-11-22FDA Approved: BUPRENORPHINE TRANSDERMAL SYSTEM — Supplemental Application (Alvogen Inc.)
The FDA approved a supplemental application for the Buprenorphine Transdermal System by Alvogen Inc. (buprenorphine transdermal patch).
-
FDA approval · 2022-11-02FDA Approved: KETOROLAC TROMETHAMINE — Original Application (Alembic Pharmaceuticals Inc.)
FDA approved Alembic Pharmaceuticals Inc.'s original application for ketorolac tromethamine, enabling a generic version of this NSAID analge…
-
FDA approval · 2022-10-21FDA Approved: KETOROLAC TROMETHAMINE — Original Application (Zydus Pharmaceuticals (USA) Inc.)
FDA approved the original application for a generic ketorolac tromethamine product (Toradol) manufactured by Zydus Pharmaceuticals (USA) Inc…
-
FDA approval · 2022-10-21FDA Approved: KETOROLAC TROMETHAMINE — Original Application (ATNAHS PHARMA US LIMITED)
FDA approved a generic ketorolac tromethamine product from ATNAHS PHARMA US LIMITED under Original Application ANDA216407.
-
FDA approval · 2022-08-25FDA Approved: KETOROLAC TROMETHAMINE — Original Application (Camber Pharmaceuticals, Inc.)
FDA approves Camber Pharmaceuticals' original application for ketorolac tromethamine (an NSAID) for short-term management of acute pain, inc…
-
FDA approval · 2022-06-17FDA Approved: BUPRENORPHINE — Supplemental Application (Actavis Pharma, Inc.)
The FDA approved a supplemental application for buprenorphine submitted by Actavis Pharma, Inc.
-
FDA approval · 2022-06-17FDA Approved: BUPRENORPHINE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for buprenorphine submitted by Sun Pharmaceutical Industries, Inc.
-
FDA approval · 2022-06-17FDA Approved: BUPRENORPHINE — Supplemental Application (Rhodes Pharmaceuticals L.P.)
FDA approved a supplemental application for buprenorphine from Rhodes Pharmaceuticals L.P. to an existing approved product.